Pharmacogenetics: potential role in the treatment of diabetes and obesity

about

A model of GLP-1 action on insulin secretion in nondiabetic subjects.Integrating Epigenomics into Pharmacogenomic Studies Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent Toxicity.Epigenetics and obesity.Genetics of type 2 diabetes.

P2860

Q33916585-84A4C246-D90A-428D-BC62-F5D9A3A09A95 Q33980155-C7CE2630-1C19-48DF-9362-08F963EAE612 Q34789161-D97CABBE-1B05-49F1-BAC9-F9D266A525B8 Q37346204-FDDDF54D-213A-4045-864B-9DCE3575D1CA Q51400285-9EA2A0DA-6688-4AF8-9651-40C564CFB9A7

P2860

Pharmacogenetics: potential role in the treatment of diabetes and obesity

Item

http://www.wikidata.org/entity/Q37142047

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacogenetics: potential role in the treatment of diabetes and obesity

@en

Pharmacogenetics: potential role in the treatment of diabetes and obesity.

@nl

type

Item

label

Pharmacogenetics: potential role in the treatment of diabetes and obesity

@en

Pharmacogenetics: potential role in the treatment of diabetes and obesity.

@nl

prefLabel

Pharmacogenetics: potential role in the treatment of diabetes and obesity

@en

Pharmacogenetics: potential role in the treatment of diabetes and obesity.

@nl

P1476

Pharmacogenetics: potential role in the treatment of diabetes and obesity

@en

P2093

Adrian Vella

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic determinants of statin intolerance

Genetic prediction of future type 2 diabetes

Genetics of Obesity in Humans

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

P304

1109-1119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.9.7.1109

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Camilleri

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18422469

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

P932

3901565

http://www.w3.org/2001/XMLSchema#string

Pharmacogenetics: potential role in the treatment of diabetes and obesity

about

P2860

P2860

Pharmacogenetics: potential role in the treatment of diabetes and obesity

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932